Association of COVID‐19 Positivity with Biomarkers of Alzheimer's Disease and Cognitive Test Performance

Abstract

Background: The amyloid cascade that causes Alzheimer's disease (AD) is associated in part with neuroinflammation, which may be affected by peripheral disease. COVID‐19 has been implicated in cognitive change, though its effect on AD biomarkers is unclear.